TREM2 Immune Target Offers Endometriosis Hope
TREM2 Immune Target Offers Endometriosis Hope
TREM2 Immune Target Offers Endometriosis Hope
Key points
اہم نکات
मुख्य बातें
- An immune-cell target called TREM2 could open the way to non-hormonal treatments for endometriosis, a painful condition affecting about 1 in 10 women.
- Researchers found that macrophages carrying TREM2 were more common in patient samples and suppressed the immune cells that should attack diseased tissue.
- The findings still need larger studies and safety checks before they can lead to a treatment, but they point to a new way of tackling the disease.
- An immune-cell target called TREM2 could open the way to non-hormonal treatments for endometriosis, a painful condition affecting about 1 in 10 women.
- Researchers found that macrophages carrying TREM2 were more common in patient samples and suppressed the immune cells that should attack diseased tissue.
- The findings still need larger studies and safety checks before they can lead to a treatment, but they point to a new way of tackling the disease.
- An immune-cell target called TREM2 could open the way to non-hormonal treatments for endometriosis, a painful condition affecting about 1 in 10 women.
- Researchers found that macrophages carrying TREM2 were more common in patient samples and suppressed the immune cells that should attack diseased tissue.
- The findings still need larger studies and safety checks before they can lead to a treatment, but they point to a new way of tackling the disease.
An immune-cell target called TREM2 could open the way to non-hormonal treatments for endometriosis, a painful condition affecting about 1 in 10 women. Researchers found that macrophages carrying TREM2 were more common in patient samples and suppressed the immune cells that should attack diseased tissue. The findings still need larger studies and safety checks before they can lead to a treatment, but they point to a new way of tackling the disease.
An immune-cell target called TREM2 could open the way to non-hormonal treatments for endometriosis, a painful condition affecting about 1 in 10 women. Researchers found that macrophages carrying TREM2 were more common in patient samples and suppressed the immune cells that should attack diseased tissue. The findings still need larger studies and safety checks before they can lead to a treatment, but they point to a new way of tackling the disease.
An immune-cell target called TREM2 could open the way to non-hormonal treatments for endometriosis, a painful condition affecting about 1 in 10 women. Researchers found that macrophages carrying TREM2 were more common in patient samples and suppressed the immune cells that should attack diseased tissue. The findings still need larger studies and safety checks before they can lead to a treatment, but they point to a new way of tackling the disease.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।